Sentiment-Signal
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
EXTREM Bilanzkorrekturen (13.03.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 13.03.2026 | Item 4.02 — Bilanzkorrekturen | EXTREM | SEC | suant to Section 13(a) of the Exchange Act. o Item 4.02 Non-Reliance on Previously Issued Financial Statements or a R |
| 01.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | to Section 13(a) of the Exchange Act. o 1 Item 5.02 Departure of Directors or Certain Officers; Election of Directors; A |
| 29.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | to Section 13(a) of the Exchange Act. o 1 2 Item 5.02 Departure of Directors or Certain Officers; Election |
| 10.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; |
| 09.08.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensat |
| 01.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 31.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 29.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 30.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 31.03.2023 | Item 4.02 — Bilanzkorrekturen | EXTREM | SEC | Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review. |
Stammdaten
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.
Unternehmen & Branche
| Name | SANUWAVE Health, Inc. |
|---|---|
| Ticker | SNWV |
| CIK | 0001417663 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 159,0 Mio. USD |
| Beta | 1,51 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 44,051,000 | 11,813,000 | 0.41 | 37,343,000 | 1,619,000 |
| 2025-09-30 | 10-Q | 11,451,000 | 10,325,000 | 0.46 | 35,599,000 | -2,931,000 |
| 2025-09-30 | 10-K | 11,270,000 | 9,688,000 | 0.39 | -7,592,000 | |
| 2025-06-30 | 10-K | 10,054,000 | 551,000 | -0.04 | -18,799,000 | |
| 2025-06-30 | 10-Q | 10,164,000 | 1,055,000 | 0.01 | 33,046,000 | -14,775,000 |
| 2025-03-31 | 10-Q | 9,342,000 | -5,676,000 | -0.66 | 30,855,000 | -17,292,000 |
| 2025-03-31 | 10-K | 9,333,000 | -6,118,000 | -0.72 | -20,812,000 | |
| 2024-12-31 | 10-K | 32,634,000 | -33,083,000 | -7.41 | 30,119,000 | -15,795,000 |
| 2024-09-30 | 10-Q | 9,360,000 | -20,657,000 | -6.49 | 21,844,000 | -60,263,000 |
| 2024-09-30 | 10-K | -21,165,000 | -6.65 | |||
| 2024-06-30 | 10-Q | 7,162,000 | 6,561,000 | 1.77 | 21,013,000 | -39,606,000 |
| 2024-06-30 | 10-K | 6,186,000 | 0.00 | |||
| 2024-03-31 | 10-K | -4,798,000 | 0.00 | |||
| 2024-03-31 | 10-Q | 5,786,000 | -4,528,000 | -1.46 | 23,324,000 | -47,595,000 |
| 2023-12-31 | 10-K | 20,398,000 | -25,807,000 | -12.19 | 22,416,000 | -44,545,000 |
| 2023-09-30 | 10-Q | 4,953,000 | -23,700,000 | -9.95 | 20,342,000 | -65,954,000 |
| 2023-06-30 | 10-Q | 4,675,000 | -7,262,000 | -0.01 | 19,197,000 | -60,838,000 |
| 2023-03-31 | 10-Q | 3,775,000 | -13,080,000 | -0.02 | 17,497,000 | -53,791,000 |
| 2022-12-31 | 10-K | 16,742,000 | -10,293,000 | -0.02 | 19,873,000 | -41,010,000 |
| 2022-09-30 | 10-Q | 4,166,000 | -1,139,000 | 0.00 | 20,109,000 | -35,313,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-21 | Opaleye Management Inc. | 10% Owner | Open Market Sale | -202 | 20.50 | -4,141.51 | -0,7% | |
| 2026-04-17 | Opaleye Management Inc. | 10% Owner | Open Market Sale | -5,000 | 20.46 | -102,305.50 | -16,4% | |
| 2026-04-17 | Opaleye Management Inc. | 10% Owner | Open Market Sale | -11,267 | 20.46 | -230,535.21 | -36,9% | |
| 2025-12-12 | MANCHESTER MANAGEMENT CO LLC | Open Market Sale | -6,500 | 21.04 | -136,788.60 | -21,9% | ||
| 2025-12-11 | MANCHESTER MANAGEMENT CO LLC | Open Market Sale | -13,500 | 31.28 | -422,277.30 | -67,6% | ||
| 2025-12-10 | MANCHESTER MANAGEMENT CO LLC | Open Market Sale | -8,625 | 30.39 | -262,129.28 | -41,9% | ||
| 2025-12-10 | MANCHESTER MANAGEMENT CO LLC | Open Market Sale | -8,625 | 30.39 | -262,129.28 | -41,9% | ||
| 2025-12-09 | MANCHESTER MANAGEMENT CO LLC | Open Market Sale | -8,785 | 30.58 | -268,678.68 | -43,0% | ||
| 2025-12-09 | MANCHESTER MANAGEMENT CO LLC | Open Market Sale | -8,785 | 30.58 | -268,678.68 | -43,0% | ||
| 2025-12-08 | MANCHESTER MANAGEMENT CO LLC | Open Market Sale | -125,400 | 30.75 | -3,856,050.00 | -616,9% | ||
| 2025-12-08 | MANCHESTER MANAGEMENT CO LLC | Open Market Sale | -2,000 | 31.60 | -63,203.40 | -10,1% | ||
| 2025-12-08 | MANCHESTER MANAGEMENT CO LLC | Open Market Sale | -125,400 | 30.75 | -3,856,050.00 | -616,9% | ||
| 2025-12-08 | MANCHESTER MANAGEMENT CO LLC | Open Market Sale | -2,000 | 31.60 | -63,203.40 | -10,1% | ||
| 2025-10-06 | Opaleye Management Inc. | 10% Owner | Open Market Purchase | 1,267 | 30.28 | 38,360.96 | +6,1% | |
| 2025-06-05 | Stegagno Peter | Officer, Chief Operating Officer | Open Market Sale | -1,862 | 27.71 | -51,596.02 | -8,3% | |
| 2025-05-15 | Cioanta Iulian | Officer, Chief Sci. and Tech. Officer | Open Market Sale | -3,639 | 31.60 | -114,992.40 | -18,4% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.